Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens

International Journal for Parasitology

Volumn 33, Issue 5-6, 2003, Pages 555-566

  Buddle, Bryce M ^a   Pollock, John M ^b   Skinner, Margot A ^a   Wedlock, D Neil ^a  

^a AGRESEARCH   (New Zealand)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

Author keywords

Cattle; Intracellular pathogen; Mycobacterium bovis; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; INACTIVATED VACCINE; LIVE VACCINE;

VACCINATION;

BACTERIAL GENOME; BIOTECHNOLOGY; CATTLE DISEASE; CELL CONTACT; CELL INTERACTION; CELLULAR IMMUNITY; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; ERADICATION THERAPY; EXPERIMENTAL INFECTION; FUNCTIONAL ASSESSMENT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RESISTANCE; LIVESTOCK; MICROBIAL ACTIVITY; MYCOBACTERIUM BOVIS; NONHUMAN; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VACCINATION; WILDLIFE;

BOS TAURUS; BOVINAE; CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS;

EID: 0037686337     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00060-2     Document Type: Review

References (90)

1. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:1994;2536-2544.
2. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45:1997;115-131.
3. Andrianarivo A.G., Rowe J.D., Barr B.C., Anderson M.L., Packham A.E., Sverlow K.W., Choromanski L., Loui C., Grace A., Conrad P.A. A POLYGEN-adjuvanted killed Neospora caninum tachyzoite preparation failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental tachyzoite challenge. Int. J. Parasitol. 30:2000;985-990.
4. Babiuk L.A., Babiuk S.L., Loehr B.I., van Drunnen Little-van den Hurk S. Nucleic acid vaccines: research tool or commercial reality. Vet. Immunol. Immunopathol. 76:2000;1-23.
5. Baldwin S.L., D'Souza C., Roberts A.D., Kelly B.P., Frank A.A., Lui M.A., Ulmer J.B., Huygen K., McMurray D.M., Orme I.M. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:1998;2951-2959.
6. Baszler T.V., McElwain T.F., Mathison B.A. Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease. Clin. Diagn. Lab. Immunol. 7:2000;893-898.
7. Berggren S.A. Field experiment with BCG vaccine in Malawi. Br. Vet. J. 137:1981;88-94.
8. Bloom B.R., Fine P.E.M. The BCG experience: implications for future vaccines against tuberculosis. Bloom B.R. Tuberculosis: Pathogenesis, Protection, and Control. 1994;531-557 American Society of Microbiology, Washington, DC.
9. Bosio C.M., Orme I.M. Effective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice. Infect. Immun. 66:1998;5048-5051.
10. Bouwer H.G., Barry R.A., Hinrichs D.J. Acquired immunity to an intracellular pathogen: immunologic recognition of L. monocytogenes-infected cells. Immunol. Rev. 158:1997;137-146.
11. Brandt L., Cunha J.F., Olsen A.W., Chilima B., Hirsch P., Appelberg R., Andersen P. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:2002;672-678.
12. Brochier B., Aubert M.F., Pastoret P.P., Masson E., Schon J., Lombard M., Chappuis G., Languet B., Desmettre P. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev. Sci. Tech. 15:1996;947-970.
13. Buddle B.M., de Lisle G.W., Pfeffer A., Aldwell F.E. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine. 13:1995;1123-1130.
14. Buddle B.M., Keen D., Thomson A., Jowett G., McCarthy A.R., Heslop J., de Lisle G.W., Stanford J.L., Aldwell F.E. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res. Vet. Sci. 59:1995;10-16.
15. Buddle B.M., Skinner M.A., Chambers M.A. Immunological approaches to the control of tuberculosis in wildlife reservoirs. Vet. Immun. Immunopathol. 74:2000;1-16.
16. Buddle B.M., Wards B.J., Aldwell F.E., Collins D.M., de Lisle G.W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine. 20:2002;1126-1133.
17. Buddle B.M., Skinner M.A., Wedlock D.N., Collins D.M., de Lisle G.W. New generation vaccines and delivery systems for control of bovine tuberculosis in cattle and wildlife. Vet. Immunol. Immunopathol. 87:2002;177-185.
18. Buxton D. Toxoplasmosis: the first commercial vaccine. Parasitol. Today. 9:1993;335-337.
19. Calmette A., Guerin C. Tuberculosis in man and animals. Boquet A., Negre L. L'Infection Bacillaire et Tuberculose. 1936;Masson, Paris.
20. Campos-Neto A., Porrozzi R., Greeson K., Coler R.N., Webb J.R., Seiky Y.A., Reed S.G., Grimaldi G. Jr. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect. Immun. 69:2001;4103-4108.
21. Caruso A.M., Serbina N., Klein E., Triebold K., Bloom B.R., Flynn J.L. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162:1999;5407-5416.
22. Cassidy J.P., Bryson D.G., Pollock J.M., Evans R.T., Forster F., Neill S.D. Early lesion formation in cattle experimentally infected with Mycobacterium bovis. J. Comp. Pathol. 119:1998;27-44.
23. Cassidy J.P., Bryson D.G., Gutiérrez Cancela M.M., Forster F., Pollock J.M., Neill S.D. Lymphocyte subtypes in experimentally induced early-stage bovine tuberculosis lesions. J. Comp. Pathol. 124:2001;46-51.
24. Chambers M.A., Williams A., Gavier-Widén D., Whelan A., Hall G., Marsh P.D., Bloom B.R., Jacobs W.R., Hewinson R.G. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin/title. Infect Immun. 68:2000;7094-7099.
25. Corner L.A., Norton S., Buddle B.M., Morris R.S. The efficacy of bacille Calmette-Guerin vaccine in wild brushtail possums (Trichosurus vulpecula). Res. Vet. Sci. 73:2002;145-152.
26. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., Cousins D.V., Robinson R.A., Huchzermeyer H.F.A.K., de Kantor I., Meslin F.-X. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg. Infect. Dis. 4:1998;59-70.
27. de Lisle G.W., Mackintosh C.G., Bengis R.G. Mycobacterium bovis in free-living and captive wildlife, including farmed deer. Rev. Sci. Tech. Off. Int. Epiz. 20:2001;86-111.
28. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
29. Doyle T.M., Stuart T.P. Vaccination of cattle with BCG. Br. Vet. J. 114:1958;3-10.
30. Elhay M.J., Andersen P. Immunological requirements for a subunit vaccine against tuberculosis. Immunol. Cell. Biol. 75:1997;595-603.
31. Feng C.G., Palendira U., Demangel C., Spratt J.M., Malin A.S., Britton W.J. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect. Immun. 69:2001;4174-4176.
32. Fensterle J., Grode L., Hess J., Kaufmann S.H. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun. J. Immunol. 163:1999;4510-4518.
33. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 346:1995;1339-1345.
34. Griffin J.F., Mackintosh C.G., Slobbe L., Thomson A.J., Buchan G.S. Vaccine protocols to optimise the protective efficacy of BCG. Tubercle Lung Dis. 79:1999;135-143.
35. Grode L., Kursar M., Fensterle J., Kaufmann S.H., Hess J. Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J. Immunol. 168:2002;1869-1876.
36. Guleria I., Teitelbaum R., McAdam R.A., Kalpana G., Jacobs W.R. Jr, Bloom B.R. Auxotrophic vaccines for tuberculosis. Nat. Med. 2:1996;334-337.
37. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14:2001;229-243.
38. Haring C.M., Traum J., Hayes F.M., Herry B.S. Vaccination of calves against tuberculosis with Calmette-Guerin culture BCG. Hilgardia. 4:1930;307-394.
39. Hayday A.C. γδ cells: A right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18:2000;975-1026.
40. Horwitz M.A., Harth G., Dillon B.J., Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA. 97:2000;13853-13858.
41. Howard C.J., Kwong L.S., Villarreal-Ramos B., Sopp P., Hope J.C. Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG. Clin. Exp. Immunol. 130:2002;190-195.
42. Jenkins M.C. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet. Parasitol. 101:2001;291-310.
43. Juffermans N.P., Leemans J.C., Florquin S., Verbon A., Kolk A.H., Speelman P., van Deventer S.J.H., van der Poll T. CpG oligodeoynucleotides enhance host defense during murine tuberculosis. Infect. Immun. 70:2002;147-152.
44. Kaufmann S.H. Antibacterial vaccines: impact of antigen handling and immune response. J. Mol. Med. 75:1997;360-363.
45. Kaufmann S.H. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:2001;20-30.
46. Kennedy D., Benedictus G. Control of Mycobacterium avium subsp. paratuberculosis infection in agricultural species. Rev. Sci. Tech. Off. Int. Epiz. 20:2001;151-179.
47. + gamma delta T cells. Infect. Immun. 70:2002;1488-1500.
48. Krebs J.R. Bovine Tuberculosis in Cattle and Badgers. 1997;Ministry of Agriculture, Fisheries and Food, London.
49. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 95:1998;270-275.
50. Lenzini L., Rottoli P., Rottoli L. The spectrum of human tuberculosis. Clin. Exp. Immunol. 27:1977;230-237.
51. + T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis. Infect. Immun. 67:1999;1034-1044.
52. Liébana E., Aranaz A., Aldwell F.E., McNair J., Neill S.D., Pollock J.M. Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells. Immunology. 99:2000;23-29.
53. Liébana E., Aranaz A., Welsh M.D., Niell S.D., Pollock J.M. In vitro T-cell activation of monocyte-derived macrophages by soluble messengers or cell-to-cell contact in bovine tuberculosis. Immunology. 100:2000;194-202.
54. Liddell S., Jenkins M.C., Collica C.M., Dubey J.P. Prevention of vertical transfer of Neospora caninum in BACLB/c mice by vaccination. J. Parasitol. 85:1999;1072-1075.
55. Livingstone P. Bovine tuberculosis. Surveillance. 29:(2):2002;20-21.
56. Lowrie D.B., Silva C.L., Colston M.J., Ragno S., Tascon R.E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine. 15:1997;834-838.
57. Matsumoto S., Yukitake H., Kanbara H., Yamada T. Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1. Vaccine. 18:1999;832-834.
58. McShane H., Brookes R., Gilbert S.C., Hill A.V. Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect. Immun. 69:2001;681-686.
59. Murphy E.A., Sathiyaseelan J., Parent M.A., Zou B., Baldwin C.L. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology. 103:2001;511-518.
60. Mustafa A.S., Cockle P.J., Shaban F., Hewinson R.G., Vordermeier H.M. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin. Exp. Immunol. 130:2002;37-42.
61. Neill S.D., Pollock J.M., Bryson D.G., Hanna J. Pathogenesis of Mycobacterium bovis infection in cattle. Vet. Microbiol. 40:1994;41-52.
62. Nicoletti P. Vaccination. Nielsen K., Duncan J.R. Animal Brucellosis. 1990;284-299 CRC Press, Boca Raton, FL.
63. Nishikawa Y., Inoue N., Xuan X., Nagasawa H., Fujisaki K., Otsuka H., Mikami T. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Vaccine. 19:2001;1381-1390.
64. Nossal G.J.V. Vaccines. Paul W.E. Fundamental Immunology. 1999;1382-1425 Lippincott-Raven, Philadelphia, PA.
65. Oliveira S.C., Splitter G.A. Immunization of mice with recombinant L7/12 ribosomal protein confers protection against Brucella abortus infection. Vaccine. 14:1996;959-962.
66. O'Reilly L.M., Daborn C.J. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tubercle Lung Dis. 76:(Suppl. 1):1995;1-46.
67. Orme I.M. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:1987;293-298.
68. Orme I.M. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? Tuberculosis. 81:2001;109-113.
69. Pollock J.M., Pollock D.A., Campbell D.G., Girvin R.M., Crockard A.D., Neill S.D., Mackie D.P. Dynamic changes in circulating and antigen-responsive T cell subpopulations post-Mycobacterium bovis infection in cattle. Immunology. 87:1996;236-241.
70. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
71. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature. 415:2002;694-701.
72. Ritacco V., Lopez B., De Kantor I.N., Barrera L., Errico F., Nader A. Reciprocal cellular and humoral immune responses in bovine tuberculosis. Res. Vet. Sci. 50:1991;365-367.
73. Schurig G.G., Sriranganathan N., Corbel M.J. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:2002;479-496.
74. Stabel J.R. Transitions in immune responses to Mycobacterium paratuberculosis. Vet. Microbiol. 77:2000;465-473.
75. Stanford J.L., Rook G.A., Bahr G.M., Dowlati Y., Ganapati R., Ghazi Saidi K., Lucas S., Ramu G., Torres P., Ho Minh L., Anstey N. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine. 8:1990;525-530.
76. Stenger S., Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2:1999;89-93.
77. Tascon R.E., Stavropoulos E., Lukacs K.V., Colston M.J. Protection against Mycobacterium tuberculosis infection by CD8 T cells requires production of gamma interferon. Infect. Immun. 66:1998;830-834.
78. van Pinxteren L.A., Ravn P., Agger E.M., Pollock J., Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol. 7:2000;155-160.
79. Velikovsky C.A., Cassataro J., Giambartolomei G.H., Goldbaum F.A., Estein S., Bowden R.A., Bruno L., Fossati C.A., Spitz M. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 70:2002;2507-2511.
80. Vordermeier H.M., Cockle P.J., Whelan A.O., Rhodes S., Chambers M.A., Clifford D., Huygen K., Tascon R., Lowrie D., Colston M.J., Hewinson R.G. Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test. Vaccine. 19:2001;1246-1255.
81. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., Hewinson R.G. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 8:2001;571-578.
82. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:2002;3026-3032.
83. Wards B.J., de Lisle G.W., Collins D.M. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will be useful for development of a live tuberculosis vaccine. Tubercle Lung Dis. 80:2000;1985-1989.
84. Watson E.A. La tuberculose, avec reference a la vaccination contre tuberculose au moyen du BCG. Bull. Off. Int. Epiz. 11:1935;718-720.
85. Wedlock D.N., Vesosky B., Skinner M.A., de Lisle G.W., Orme I.M., Buddle B.M. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis. Infect. Immun. 68:2000;5809-5815.
86. Wedlock D.N., Keen D.L., McCarthy A.R., Andersen P., Buddle B.M. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins. Vet. Immunol. Immunopathol. 86:2002;79-88.
87. Wijngaard P.L.J., Metzelaar M.J., MacHugh N.D., Morrison W.I., Clevers H.C. Molecular characterisation of the WC1 antigen expressed specifically on bovine CD4-CD8-gamma-delta T-lymphocytes. J. Immunol. 149:1992;3273-3277.
88. Wilkins M.F., O'Connell E., Te Punga W.A. Toxoplasmosis in sheep. I. Effect of a killed vaccine on lambing losses caused by experimental challenge with Toxoplasma gondii. N.Z. Vet. J. 35:1986;31-43.
89. Woodruff H.A., Gregory T.S. The prevention of tuberculosis in cattle. Further investigation to determine the value of BCG vaccine for the prevention of tuberculosis. J. Council Sci. Ind. Res. 2:1929;1-14.
90. + T cell and natural killer cell-dependent killing Mycobacterium tuberculosis by human monocytes. Am. J. Respir. Crit. Care Med. 158:1998;395-403.